In DepthCOVID-19

Side effect worry grows for AstraZeneca vaccine

See allHide authors and affiliations

Science  02 Apr 2021:
Vol. 372, Issue 6537, pp. 14-15
DOI: 10.1126/science.372.6537.14

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed.  Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

  • RE: Is it Sensible to Restrict AstraZeneca by Age?

    All vaccines have side effects, some more so than others, especially when clinical laboratory trials and development of vaccines for COVID-19 have progressed at warp speed.

    A small number of AstraZeneca vaccine recipients have been found to experience rare blood coagulation, especially for women under 65 years, and low platelet counts, especially for individuals recently injected with a specific batch, so much so that its safety has been called into question.

    A number of countries have restricted the vaccine to those above a certain age, be it 50, 55, or 60 years of age, as younger cohorts seem to have a greater risk of blood clotting.

    The added presumption that younger adults are less likely to be infected by COVID-19 has been belied by the findings that the mutated strain, variant, or lineage from Brazil has targeted those aged from 18 to 45 years, with more highly transmissible, infectious, contagious, and deadly effects than the original wild-type coronavirus (COVID-19).

    Several national risk assessment panels and medical societies have approved the safety of the vaccine, especially in comparison with the damaging consequences of not being vaccinated against COVID-19.

    Unlike some European countries, the UK has not reported an unexpected number of vaccinated patients suffering from blood clots, although evidence has not been presented according to age.

    Convincing individuals that vaccines are safe and effective, albeit with unkn...

    Show More
    Competing Interests: I have no competing interests.

Stay Connected to Science

Navigate This Article